Text Registration
Copyright Title
Hyper-Immune Products Chart - 2008
Status
Published
on 6 Mar 2008
Year of Creation
2007
Copyright Claimant
Blood Diagnostics, Inc
Registration Number
TX0006841539
on 6 Mar 2008Copyright Summary
The U.S. Copyright record (Registration Number: TX0006841539) dated 6 Mar 2008, pertains to an electronic file (eService) titled "Hyper-Immune Products Chart - 2008" created in 2007. The copyright holder is Blood Diagnostics, Inc, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Blood Diagnostics, Inc.
Application Details
Registration Number
TX0006841539
Registration Date
3/6/2008
Year of Creation
2007
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Blood Diagnostics, Inc
Physical Description
Print material, 1 p
Preexisting Material
Format of chart
Notes
Material Matter Claimed Note: The text including the selection, coordination and arrangement of the text contained within the chart
Previous Registration Note: 2002, TX5-529-5582007, TX6-566-564
Statements
Application Title Statement: Hyper-Immune Products Chart - 2008
Author Statement: Blood Diagnostics, Inc employer for hire Citizenship: United States Authorship: Literary work comprising informational charts
© 2023 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.